The Global Pharma Healthcare – Glocare Group is an integrated pharmaceutical company with operations spanning finished formulations, CRO services, and API manufacturing, serving patients and partners in over 40 countries across Europe, Latin America, MENA, Asia, Africa, and CIS. Finished Formulations: EU GMP Certified Global Pharma Healthcare Limited (GPHC) is our finished dosage formulations (FDF) division with a portfolio consisting of 25+ therapeutic segments. Its facility is EU GMP and WHO-GMP certified, with further approvals from numerous health ministries across Africa and Asia. It has developed strong competencies in providing CMO and CDMO services to our partners worldwide. GPHC produces a range of dosage forms including tablets, capsules, liquid orals, dry syrups, sterile/non-sterile ointments, sachets, parenterals, eye/ear formulations, and food supplements. With over 700 product registrations globally, it is committed to delivering affordable, high-quality medicines worldwide. By combining strong in-house R&D with backward API integration, GPHC ensures quality, supply security, and competitiveness across markets. API Manufacturing: EU GMP Certified Our API division, Global Pharma (Cheyyar), is anchored by a state-of-the-art EU-GMP approved facility equipped with SSR and GLR reactors ranging from 1-10 kL allowing for 41 kL total capacity. It currently specialises in fluoroquinolone APIs that are CEP grade (levofloxacin and ofloxacin) or awaiting CEP registration (ciprofloxacin, norfloxacin, moxifloxacin, and gatifloxacin). We are also actively expanding our portfolio, with a robust pipeline of new products under development that will be ready for launch in the near future. The firm is looking to provide CMO, CDMO, and CRAMS services to partners across the globe. Full Service CRO Through Glocare Labs CRO, the group provides end-to-end research solutions, including BA/BE studies, clinical trial management, regulatory submissions and pharmacovigilance.
